Trilogie was founded to solve a critical gap in ubiquitin-proteasome system (UPS) research: the paucity of high-specific-activity, biologically validated reagents and services that reflect the true complexity of UPS biology. Whether you’re mapping E3-substrate interactions, screening DUB inhibitors, or engineering protein degraders, we believe experimental outcomes depend on functional precision, starting with the reagents themselves.

Our focus:
Expression scouting and optimization for ligases, substrates, adaptors, and complex UPS proteins

Mechanism-aligned assay development for ubiquitylation cascades and degrader mode-of-action studies

Growing catalog of ready-to-use UPS tools designed to support academic and drug discovery researchers with reagents that perform reliably

Trilogie Bioscience

Org chart

Teams

Offices